1.
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
2.
3.
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
